We found that the expression levels of CASP4 in ccRCC samples were significantly higher than that in normal samples and that the OS of patients with high CASP4 mRNA levels was worse than that of patients with low expression of CASP4 mRNA. This evidence concerns the gene CASP4 and nonpapillary renal cell carcinoma.